April 2026: Notable Drug Approvals

Summary: In April 2026, several exciting new medicines were approved. A major highlight is Foundayo, a new daily pill for weight loss that works like popular injectable drugs, making it much easier for people to manage their weight. Other major breakthroughs include Otarmeni, a sci-fi-like gene therapy that treats a specific type of genetic hearing loss, and Tzield, which helps delay severe Type 1 diabetes in young children. There are also new treatments for asthma, Alzheimer's agitation, HIV, and lupus.

For more details, see rssapp-empr-com at empr.com/news/april-2026-notable-drug-approvals/ (opens in new tab)